(Q80954340)
Statements
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer (English)
Ronald Hoekstra
Ferry A L M Eskens
Ate van der Gaast
Harry J M Groen
Raymond A Knight
Robert A Carr
Rod A Humerickhouse